EXPEDITION

Serial Number 98785584
730

Registration Progress

Application Filed
Oct 4, 2024
Under Examination
Nov 11, 2025
Approved for Publication
Sep 16, 2025
Published for Opposition
Sep 16, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Nov 11, 2026 317 days

Trademark Image

EXPEDITION

Basic Information

Serial Number
98785584
Filing Date
October 4, 2024
Published for Opposition
September 16, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 11, 2025
Application
Pending
Classes
005 009 042

Rights Holder

EXPEDITION MEDICINES, INC.

03
Address
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142

Ownership History

Flagship Labs 94, Inc.

Original Applicant
03
Cambridge, MA

EXPEDITION MEDICINES, INC.

New Owner Before Publication #1
03
CAMBRIDGE, MA

EXPEDITION MEDICINES, INC.

Owner at Publication
03
CAMBRIDGE, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

Next Deadline
317 days remaining
NOA E-Mailed - SOU Required
Due Date
November 11, 2026
Extension Available
Until May 11, 2027

Application History

21 events
Date Code Type Description Documents
Dec 12, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 11, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 11, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 11, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 11, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 16, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 16, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 10, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 31, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 31, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 31, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 1, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 1, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 1, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 9, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 3, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 5, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 4, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; protein-based and small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; protein-based and small molecule pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders
Class 009
Downloadable software for use in the pharmaceuticals and healthcare fields, namely, for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable software for providing life science analytics
Class 042
Software as a service (SAAS) services featuring software using artificial intelligence for use in the fields of healthcare for enabling and facilitating molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; software as a service (SAAS) services featuring software using artificial intelligence for use in the biotechnology field for discovering and designing biomolecules and chemical structures; software as a service (SAAS) services featuring software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical and genomic research; providing temporary use of on-line non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, research and analysis services for the design and characterization of chemical and biologic therapeutic products; research services in the fields of genomic, transcriptomic, and proteomic analysis; genomic and proteomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics and proteomics; medical research, namely, compiling data for research purposes in the field of genomics and proteomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, and meta-transcriptomics

Classification

International Classes
005 009 042